highmark blue cross blue shield glp 1 coverage BCBS returns to profit after cutting GLP-1 coverage, workforce Weight Loss Drugs versus Bariatric

Eli Lilly - Manufacturing Investment (February 2026): Eli Lilly reported $1.5 billion pre-launch inventory for orforglipron and announced new manufacturing facilities as part of $27 billion investment drive [4]

By maintaining muscle, you improve your bodys ability to process glucose, which reduces the metabolic load on your liver and protects your heart

The plan aims to lower total symptom load without blurring medication roles: ketotifen as baseline stabilization, gabapentin for burden reduction, and diphenhydramine as a clearly defined rescue option for acute spikes

It will identify and describe the direct-to-consumer market for these products in the US, including advertising claims regarding the safety and efficacy of compounded GLP-1 products